The Advanced Medical Technology Association (AdvaMed) said it was encouraged by President Trump’s announcement April 9 of a three-month pause on reciprocal tariffs, with the exception of China.
“We are encouraged by the President’s announcement of a 90-day pause on reciprocal tariffs. This is an important decision that restores some short-term certainty to global markets, including the American medtech industry, which is number one globally,” said AdvaMed President and CEO Scott Whitaker.
In February, the medical industry organization said it had shared concerns with the Trump administration about the potential impact tariffs could have on the medical technology supply chain that American patients depend on for their care.
“Moving forward, we will spend the next 90 days working with the President and his senior team to ensure the unique role of the medtech industry is protected, with the hope that the ultimate outcome is ‘zero for zero’ tariffs on medtech with all key trading partners,” Whitaker added.
As part of a retaliation against new tariffs imposed by the Trump administration, China announced April 4 that it would limit export of rare earth elements, including several used in medical imaging and treatments. It also launched investigations related to imports of CT x-ray tubes.
According to a report on NPR, most countries will be left with 10% tariffs on their exports to U.S., while China, based on its latest actions, will now face tariffs of 125%.
